ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Healthtech Startup Bisu Raises $3.2M in Seed Round, Will Collaborate With ASICS on Future Projects

Funding to support launch of Bisu's "lab-on-a-chip" urine and saliva analyzer


Bisu Body Coach consists of a disposable microfluidic test stick, a reader which automates the test process, and a companion mobile app.

TOKYO - October 6, 2021 - (Newswire.com)

Bisu, Inc., a startup that helps people improve their health and wellness through lab-grade testing at home, today announced ­a new round of seed funding of $3.2 million. Leading the round was Korean biotech investor QUAD, with participation from ASI­CS Ventures Corporation, 15th Rock Ventures, Pacifico Investments, and SOSV, the world's most active investor in hardware and health tech investing for the third time. The funding will enable Bisu to bring to market Bisu Body Coacha portable "home health lab" for personalized nutrition and lifestyle advice through easy, accurate urine and saliva testing. Bisu also reached an agreement with ASICS Corporation to collaborate on health and fitness service initiatives.

Bisu Body Coach consists of a disposable test stick and a reader that syncs with a companion smartphone app. The microfluidic "lab-on-a-chip" technology used in the test stick enables reliable, precise and automated measurements of a wide range of biomarkers in just two minutes. The app provides feedback on key nutrition indicators such as hydration, minerals and vitamins, and recommendations are personalized based on the user's goals, dietary preferences, activity, sleep and weight. Bisu Body Coach is currently in beta, with a pipeline of additional test sticks covering training intensity, hormones, and pet and baby health. Bisu and ASICS will work together on future initiatives aimed to enhance personal health and athletic performance. ASICS' investment follows Bisu's victory in the U.S. Sports & Fitness Industry Association's startup competition — one of the industry's major events for which more than 100 sports and fitness executives served as judges.

"We decided to invest in Bisu because we believe its home health lab technology, which provides affordable access to actionable health data, is very innovative and has huge potential," says Hiroaki Kageyama, President of ASICS Ventures. "We are thrilled to build this collaboration with Bisu as a strategic partner".

"We've been flushing away insight and data for centuries," says Duncan Turner, SOSV General Partner and HAX Managing Director. "Bisu is showing how valuable capturing and acting on that data can be for human health".

"This funding is a major vote of confidence from a group of investors who are both tech-savvy, consumer-focused and globally minded," says Daniel Maggs, Co-founder & CEO at Bisu. "We are delighted to announce our collaboration with ASICS. ASICS shares our passion for making beautiful yet scientifically rigorous products in the spirit of Japanese craftsmanship, yet is also a modern, globally-recognized brand," says Wojciech Bula, PhD, Co-founder & CTO.

About Bisu

Bisu is a health IoT startup developing at-home health tracking devices using microfluidic "lab-on-a-chip" technology. The company is a graduate of the HAX hardware accelerator and has won numerous endorsements and awards, including from Johnson & Johnson Innovation, MedTech Innovator, Edison Awards, UK Tech Rocketship Awards and British Business Awards.

Please address all press inquiries to press@bisu.com. Please see "Related Files" below for a set of press FAQs.


Related Files
Bisu press FAQs (seed round).pdf

Related Images

Bisu Body Coach consists of a disposable microfluidic test stick, a reader which automates the test process, and a companion mobile app.


The extending and retracting test stick enables a few drops of sample to be cleanly captured during urination. The reader draws the sample inside the microfluidic chip inside the test stick.


Different test sticks can be created with different combinations of biomarkers. No urine or saliva enters the reader, so it can be used hygienically by multiple people at home, the gym or the office.



Press Release Service by Newswire.com

Original Source: Healthtech Startup Bisu Raises $3.2M in Seed Round, Will Collaborate With ASICS on Future Projects
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.